Invitrogen Sues Oxford Biomed Over Protein Patent
Invitrogen Corp. has sued Oxford Biomedical Research Inc. and Vanderbilt University, seeking a declaration that it does not infringe a patent covering recombinant protein technology and that the patent does not...To view the full article, register now.
Already a subscriber? Click here to view full article